Pages that link to "Q84334066"
Jump to navigation
Jump to search
The following pages link to Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population (Q84334066):
Displaying 22 items.
- Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies (Q28076563) (← links)
- Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population of African descent (Q34150179) (← links)
- Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects (Q34568211) (← links)
- Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients (Q34990296) (← links)
- Transcriptome profiling of a multiple recurrent muscle-invasive urothelial carcinoma of the bladder by deep sequencing (Q35119047) (← links)
- GSTM1 and GSTT1 copy number variation in population-based studies of endometrial cancer risk (Q35169542) (← links)
- Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent (Q35190805) (← links)
- Identification of rare germline copy number variations over-represented in five human cancer types (Q35238058) (← links)
- Impact of urinary bladder cancer risk variants on prognosis and survival. (Q35717096) (← links)
- Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer (Q36401990) (← links)
- GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer (Q36680283) (← links)
- Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy (Q36765379) (← links)
- Identification of germline genomic copy number variation in familial pancreatic cancer (Q37256603) (← links)
- GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects (Q37290556) (← links)
- Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia (Q38959826) (← links)
- Genetic variants confer susceptibility to urinary bladder cancer: an updated list of confirmed polymorphisms (Q42769306) (← links)
- Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies (Q47113559) (← links)
- Lightning-fast genome variant detection with GROM. (Q47143107) (← links)
- Germline copy number variations are associated with breast cancer risk and prognosis (Q47425936) (← links)
- GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer. (Q54272723) (← links)
- GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma (Q64094406) (← links)
- Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia (Q93061582) (← links)